Ingrown Toenails : Surgery Only Versus Surgery + Chemical Cauterization With TCA

Sponsor
University Hospital, Caen (Other)
Overall Status
Recruiting
CT.gov ID
NCT04921540
Collaborator
(none)
50
2
2
24
25
1

Study Details

Study Description

Brief Summary

Ingrown toenail is a very common disease in the general population that touches young adults. There are lots of treatments from local care of pedicure to surgery with matricectomy. Gold standard of symptomatic and painful ingrown toenail is the simple surgery with matricectomy and with suture or directed healing pad.

For many years chemical cauterisation with phenolic acid is used, a method with very few relapses and with a more simple pad. However, because of a lack of information about this phenolic acid, the pharmaceutical laboratory withdrew it from the market.

The new method to replace phenolic acid is trichloroacetic acid, used mainly in cosmetics for peeling. This method was already compared to phenolic acid and showed equal results with fewer laps of application and a low cost. The comparison between acid trichloroacetic method and the gold standard surgery was never done and will be the goal of this study.

It's an open, non randomised, comparative, multicentric (2 centers) study with two groups :

common surgery and surgery with chemical cauterisation For this study the investigators will compare between the two groups : gain of quality of life at one month after surgery, difference of pain between before, one week and one month after surgery, the occurrence of adverse events and number of relapses at one year.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ingrown toenails with surgery with chemical cauterisation
  • Procedure: Ingrown toenails with only surgery
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Etude Comparative Multicentrique Prospective évaluant la Prise en Charge Chirurgicale associée à Une cautérisation Chimique Par Acide TCA Par Rapport à la Prise en Charge Chirurgicale Standard Dans le Traitement de l'Ongle incarné
Actual Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dermatologic intervention

Surgery with chemical cauterisation TCA

Procedure: Ingrown toenails with surgery with chemical cauterisation
Removal of the ingrown lateral part of the toenail and chemical cauterisation

Active Comparator: Orthopedic intervention

Only surgery

Procedure: Ingrown toenails with only surgery
Removal of the ingrown lateral part of the toenail with directed Healing pad

Outcome Measures

Primary Outcome Measures

  1. Relapses [one year]

    Relapses of ingrown toenail on the operated nail

Secondary Outcome Measures

  1. Gain of quality of life [Baseline and one month after the surgery]

    Quality of life will be measured with the Dermatology Life Quality Index adapted to the nail, there are 9 questions that will be filled by the patient. Each questions have 4 possibilities to 0 (no problem) to 3(hugely). So the score go to 0 to 27. Questions are, on last 7 days : Did your nail itch, burn or hurt you ? Did you feel embarrassed or complexed by your nail ? Did you have problem to go shopping, to do the housework ? Did you have problem to put on your shoes? Did your nail problem affect your hobbies and activity ? Did you have problem to do sport ? Did your nail embarrased you in your job or your studies ? Did your nail complicate your relationship's with your friends, parents or spouse? Did your nail deteriorate your sexual life ?

  2. Complications [At one week and one month after surgery]

    Bleeding, infection, pain

  3. Pain on the nail [Baseline, one week and one month after surgery]

    Pain report on a numeric scale of pain to 0 (no pain) to 10(worst pain possible)

  4. Time before restart sport [Restart sport at one month yes/no]

    Time to recover a normal physical activity

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of ingrown toenail

  • Patient informed and with signed informed consent

Exclusion Criteria:
  • Medical history of ingrown toenail on the concerned nail

  • Other nail disease

  • Pregnancy

  • Allergy to local anesthetic or to trichloroacetic acid

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre hospitalier universitaire de CAEN Caen Normandie France 14000
2 Centre hospitalier Mémorial France Etats Unis Saint-Lô Normandie France 50000

Sponsors and Collaborators

  • University Hospital, Caen

Investigators

  • Study Director: Pr DOMPMARTIN ANNE, CHU CAEN

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT04921540
Other Study ID Numbers:
  • 20-090
First Posted:
Jun 10, 2021
Last Update Posted:
Jun 10, 2021
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Caen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 10, 2021